IVOG vs. BOUT
IVOG (Vanguard S&P Mid-Cap 400 Growth ETF) and BOUT (Innovator IBD Breakout Opportunities ETF) are both Mid Cap Growth Equities funds - IVOG tracks the S&P MidCap 400 Growth Index while BOUT tracks the IBD Breakout Stocks Total Return Index. Both are passively managed. Over the past 5 years, IVOG returned 8.21%/yr vs 7.49%/yr for BOUT. A 0.77 correlation means they provide meaningful diversification when combined. IVOG charges 0.10%/yr vs 0.80%/yr for BOUT.
Performance
IVOG vs. BOUT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IVOG achieves a 16.96% return, which is significantly lower than BOUT's 27.17% return.
IVOG
- 1D
- -1.05%
- 1M
- -1.65%
- 6M
- 11.10%
- YTD
- 16.96%
- 1Y
- 23.29%
- 3Y*
- 14.86%
- 5Y*
- 8.21%
- 10Y*
- 11.06%
BOUT
- 1D
- -1.06%
- 1M
- -2.85%
- 6M
- 19.86%
- YTD
- 27.17%
- 1Y
- 27.33%
- 3Y*
- 13.21%
- 5Y*
- 7.49%
- 10Y*
- —
IVOG vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
IVOG Vanguard S&P Mid-Cap 400 Growth ETF | 16.96% | 7.34% | 15.62% | 17.36% | -19.08% | 18.85% | 22.60% | 26.13% | -18.64% |
BOUT Innovator IBD Breakout Opportunities ETF | 27.17% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 50.56% | 20.59% | -30.42% |
Correlation
The correlation between IVOG and BOUT is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.81 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.82 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.80 |
Correlation (All Time) Calculated using the full available price history since Sep 13, 2018 | 0.77 |
The correlation between IVOG and BOUT has been stable across timeframes, ranging from 0.77 to 0.82 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IVOG vs. BOUT — Risk / Return Rank
IVOG
BOUT
IVOG vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IVOG | BOUT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.22 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.41 | 2.33 | +0.08 |
| Martin ratioReturn relative to average drawdown | 9.23 | 6.78 | +2.45 |
Loading charts...
Drawdowns
IVOG vs. BOUT - Drawdown Comparison
The maximum IVOG drawdown since its inception was -39.32%, which is greater than BOUT's maximum drawdown of -36.98%. Use the drawdown chart below to compare losses from any high point for IVOG and BOUT.
Loading charts...
Drawdown Indicators
| IVOG | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.32% | -36.98% | -2.34% |
Max Drawdown (1Y)Largest decline over 1 year | -9.69% | -11.76% | +2.07% |
Max Drawdown (3Y)Largest decline over 3 years | -25.61% | -25.31% | -0.30% |
Max Drawdown (5Y)Largest decline over 5 years | -29.31% | -28.28% | -1.03% |
Max Drawdown (10Y)Largest decline over 10 years | -39.32% | — | — |
Current DrawdownCurrent decline from peak | -3.90% | -5.64% | +1.74% |
Average DrawdownAverage peak-to-trough decline | -5.85% | -12.23% | +6.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.53% | 4.04% | -1.51% |
Volatility
IVOG vs. BOUT - Volatility Comparison
The current volatility for Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) is 5.56%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 7.62%. This indicates that IVOG experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IVOG | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.56% | 7.62% | -2.06% |
Volatility (6M)Calculated over the trailing 6-month period | 13.92% | 17.74% | -3.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.90% | 22.51% | -4.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.72% | 19.82% | +0.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.59% | 23.01% | -2.42% |
IVOG vs. BOUT - Expense Ratio Comparison
IVOG has a 0.10% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Dividends
IVOG vs. BOUT - Dividend Comparison
IVOG's dividend yield for the trailing twelve months is around 0.55%, more than BOUT's 0.27% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 0.27% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% | 0.00% | 0.00% | 0.00% |
IVOG Vanguard S&P Mid-Cap 400 Growth ETF | 0.55% | 0.64% | 0.79% | 1.15% | 1.05% | 0.47% | 0.74% | 1.17% | 1.01% | 0.93% | 1.11% | 1.04% |
Frequently Asked Questions
IVOG and BOUT have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BOUT has higher volatility (7.62%) compared to IVOG (5.56%). In terms of maximum drawdown, IVOG dropped -39.32% vs BOUT's -36.98%.
On 5-year performance, IVOG leads with 8.21% vs 7.49% for BOUT. On fees, IVOG is cheaper at 0.10% per year. On volatility, IVOG has been the lower-risk option at 5.56%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IVOG has performed better with a 8.21% return vs 7.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IVOG is cheaper with a 0.10% expense ratio, compared with 0.80% for BOUT.
IVOG has the higher dividend yield at 0.55%, compared with 0.27% for BOUT.
IVOG tracks S&P MidCap 400 Growth Index, while BOUT tracks IBD Breakout Stocks Total Return Index. They also come from different issuers: Vanguard and Innovator. Their fees differ too: 0.10% for IVOG and 0.80% for BOUT.
IVOG currently has the higher Sharpe Ratio (1.31 vs 1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IVOG and BOUT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer